Abstract | BACKGROUND: METHODS: A total of 35 patients with chronic hepatitis B and decompensated cirrhosis were treated with danshao huaxian 1.2 g. p.o. tid daily. Before the treatment, HBV- DNA in serum was positive in all patients. Ten patients had Child-Pugh class B and 25, class C hepatitis B. Seven patients underwent liver transplantation within 6 months of initial treatment. Of the 10 patients of class B, 5 died within 6 months, and the other 5 did not complete the treatment for some reasons; the 25 patients of class C were treated for at least 6 months (mean=19 months). RESULTS: In most of the 25 patients, liver function was improved slowly but markedly after 9 months of treatment, showing a decreased level of serum bilirubin from 67+/-13 to 30+/-4 micromol/L (P<0.05, baseline vs. 6 months), an increased level of serum albumin from 27+/-1 to 34+/-1 g/L (P<0.05) and a decreased level of Child-Pugh score from 10.3+/-0.4 to 7.5+/-0.5 (P<0.05). Three patients developed resistance to danshao huaxian because of a mutation in the YMDD motif, but liver function was not deteriorated. Inhibition of viral replication with danshao huaxian resulted in a significant improvement of liver function in patients with decompensated HBV cirrhosis, but the long-term results remain uncertain. CONCLUSION:
|
Authors | Ming-Liang Cheng, Tong Lu, Yu-Mei Yao, Xiao-Xia Geng |
Journal | Hepatobiliary & pancreatic diseases international : HBPD INT
(Hepatobiliary Pancreat Dis Int)
Vol. 5
Issue 1
Pg. 48-51
(Feb 2006)
ISSN: 1499-3872 [Print] Singapore |
PMID | 16481282
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Capsules
- Drugs, Chinese Herbal
- Hepatitis B Antibodies
- Hepatitis B Surface Antigens
- Hepatitis B e Antigens
- RNA, Viral
|
Topics |
- Capsules
- Drugs, Chinese Herbal
(therapeutic use)
- Female
- Follow-Up Studies
- Hepatitis B Antibodies
(analysis)
- Hepatitis B Surface Antigens
(analysis)
- Hepatitis B e Antigens
(analysis)
- Hepatitis B virus
(drug effects, physiology)
- Hepatitis B, Chronic
(complications, virology)
- Humans
- Liver Cirrhosis
(drug therapy, etiology)
- Male
- Middle Aged
- RNA, Viral
(analysis)
- Retrospective Studies
- Treatment Outcome
- Virus Replication
(drug effects)
|